Excelsior Sciences raises $95 million, including a $70 million Series A, to transform small molecule discovery and manufacturing. The round is co-led by Deerfield Management, Khosla Ventures, and Sofinnova Partners.
Amount Raised
$70 Million
Round Type
Series A
New YorkManufacturingBiotechnologyInvestors
Description
Excelsior Sciences has raised $95 million to reinvent the process of discovering and manufacturing small molecules. The financing includes a $70 million Series A co-led by Deerfield Management, Khosla Ventures, and Sofinnova Partners, along with a $25 million grant from New York’s Empire State Development. Other participants include Cornucopian Capital, Eli Lilly and Company, and Illinois Ventures.
Quick answer
Excelsior Sciences raised $70 Million in a Series A round, dated December 3, 2025. Investors: Cornucopian Capital, Eli Lilly And Company, Illinois Ventures, Deerfield Management, Khosla Ventures and Sofinnova Partners. Excelsior Sciences is based in New York, New York, United States.
- How much did Excelsior Sciences raise?
- Excelsior Sciences raised $70 Million in a Series A round on December 3, 2025.
- Who invested in Excelsior Sciences?
- Cornucopian Capital, Eli Lilly And Company, Illinois Ventures, Deerfield Management, Khosla Ventures and Sofinnova Partners are named as investors in this round.
- What does Excelsior Sciences do?
- Excelsior Sciences is a company developing a proprietary form of chemistry that machines can utilize for closed-loop drug discovery and manufacturing.
- Where is Excelsior Sciences based and how big is it?
- Excelsior Sciences is based in New York, New York, United States. Fundz records about 11 employees.
- Who are the decision-makers at Excelsior Sciences?
- Fundz holds 1 contact at Excelsior Sciences, including the Chief Technology Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as Excelsior Sciences that raised within 45 days of this round, from Fundz verified event records.
- Novabay raised $134M on January 16, 2026.
- Transition Metal Solutions raised $6M (Seed) on January 15, 2026.
- Route 92 Medical raised $50M on January 13, 2026.
- Conavi Medical raised $700K (Seed) on January 13, 2026.
- Avenue Biosciences raised $5.7M (Seed) on January 12, 2026.
- iBio raised $26M on January 8, 2026.
Who to call at Excelsior Sciences, and when
A new round usually means Excelsior Sciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Excelsior Sciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Excelsior Sciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Excelsior Sciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Excelsior Sciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansExcelsior Sciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.